The Chanelle Group provides a spectrum of services in areas of research and development, registration and production of generic pharmaceuticals for both Human and Veterinary Pharmaceuticals. Headquartered in Loughrea Co. Galway, the company was founded in 1985 by Michael H. Burke, a Veterinary Surgeon. The company currently employs 385 people.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

ARDELYX ANNOUNCES ACCEPTANCE OF NEW DRUG APPLICATION FOR TENAPANOR FOR HYPERPHOSPHATEMIA IN CHINA

Globenewswire | July 14, 2023

news image

Ardelyx, Inc. a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that a New Drug Application (NDA) for tenapanor has been accepted for review by China’s Center for Drug Evaluation of the National Medical Products Administration (NMPA) for the control of serum phosphorus in adult patients with chronic kidney disease on hemodialysis. This acceptance tri...

Read More

CPD and Learning

MIRAVO AND SEARCHLIGHT CLOSE PREVIOUSLY ANNOUNCED ARRANGEMENT PLAN

Miravo Healthcare | March 16, 2023

news image

Nuvo Pharmaceuticals Inc., which operates as Miravo Healthcare (Miravo), and Searchlight Pharma Inc., a Canadian specialty firm, have recently announced the closing of the previously announced plan of arrangement of Miravo with Searchlight. As per the arrangement terms, Searchlight acquired all the outstanding common shares of Miravo in exchange for $1.35 per share in cash, and the Miravo common shares will be removed from the Toronto Stock Exchange. Miravo will also apply to cease being a...

Read More

Pharma Tech

GANNEX RECEIVED U.S. FDA FAST TRACK DESIGNATION FOR ITS NASH DRUG CANDIDATE ASC42,AN FXR AGONIST

Gannex | December 14, 2020

news image

Gannex, an entirely claimed organization of Ascletis Pharma Inc. (HKEX:1672) and completely committed to the R&D and commercialization of new medications in the field of NASH, reported today that it got Fast Track assignment from the U.S. Food and Drug Administration (FDA) for its non-alcoholic steatohepatitis (NASH) drug applicant ASC42. The U.S. FDA's Fast Track advancement program is intended to encourage the turn of events and speed up the survey of medications that ha...

Read More

Pharmacy Market

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

news image

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More
news image

Pharmacy Market

ARDELYX ANNOUNCES ACCEPTANCE OF NEW DRUG APPLICATION FOR TENAPANOR FOR HYPERPHOSPHATEMIA IN CHINA

Globenewswire | July 14, 2023

Ardelyx, Inc. a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that a New Drug Application (NDA) for tenapanor has been accepted for review by China’s Center for Drug Evaluation of the National Medical Products Administration (NMPA) for the control of serum phosphorus in adult patients with chronic kidney disease on hemodialysis. This acceptance tri...

Read More
news image

CPD and Learning

MIRAVO AND SEARCHLIGHT CLOSE PREVIOUSLY ANNOUNCED ARRANGEMENT PLAN

Miravo Healthcare | March 16, 2023

Nuvo Pharmaceuticals Inc., which operates as Miravo Healthcare (Miravo), and Searchlight Pharma Inc., a Canadian specialty firm, have recently announced the closing of the previously announced plan of arrangement of Miravo with Searchlight. As per the arrangement terms, Searchlight acquired all the outstanding common shares of Miravo in exchange for $1.35 per share in cash, and the Miravo common shares will be removed from the Toronto Stock Exchange. Miravo will also apply to cease being a...

Read More
news image

Pharma Tech

GANNEX RECEIVED U.S. FDA FAST TRACK DESIGNATION FOR ITS NASH DRUG CANDIDATE ASC42,AN FXR AGONIST

Gannex | December 14, 2020

Gannex, an entirely claimed organization of Ascletis Pharma Inc. (HKEX:1672) and completely committed to the R&D and commercialization of new medications in the field of NASH, reported today that it got Fast Track assignment from the U.S. Food and Drug Administration (FDA) for its non-alcoholic steatohepatitis (NASH) drug applicant ASC42. The U.S. FDA's Fast Track advancement program is intended to encourage the turn of events and speed up the survey of medications that ha...

Read More
news image

Pharmacy Market

YANGTZE RIVER PHARMACEUTICAL GROUP SELECTS TRACELINK PLATFORM FOR GLOBAL COMPLIANCE

Yangtze River Pharmaceutical, TraceLink | May 06, 2021

TraceLink Inc., the leading digital network platform company, today announced that Yangtze River Pharmaceutical Group has selected TraceLink's global compliance solution to aid its plans for global growth. As the company gears up for international market expansion this year, Yangtze River Pharmaceutical Group (YRPG) will use TraceLink's multienterprise compliance applications and industry-leading digital supply network to comply with track and trace requirements in multiple markets, incl...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us